4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-19-054654
CIK 0001607678other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 6:27 PM ET
Size
5.4 KB
Accession
0001209191-19-054654
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-10-31+2,500→ 2,500 totalExercise: $6.47From: 2020-10-31Exp: 2029-10-31→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 6:27 PM ET
- Size
- 5.4 KB